{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T14:59:34Z","timestamp":1788965974320,"version":"build-2803163510"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T00:00:00Z","timestamp":1685318400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CM20\/00138"],"award-info":[{"award-number":["CM20\/00138"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["75N93021C00014, 75N93019C000510, P01AI097092, R01AI142086, U01AI165452, U19AI168631, 75N93019C00051, 75N93021C00014, P01AI097092, R01AI145870 , R01AI141226"],"award-info":[{"award-number":["75N93021C00014, 75N93019C000510, P01AI097092, R01AI142086, U01AI165452, U19AI168631, 75N93019C00051, 75N93021C00014, P01AI097092, R01AI145870 , R01AI141226"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>Antibodies elicited by seasonal influenza vaccines mainly target the head of hemagglutinin (HA). However, antibodies against the stalk domain are cross-reactive and have been proven to play a role in reducing influenza disease severity. We investigated the induction of HA stalk-specific antibodies after seasonal influenza vaccination, considering the age of the cohorts.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A total of 166 individuals were recruited during the 2018 influenza vaccine campaign (IVC) and divided into groups: &amp;lt;50 (n = 14), 50\u201364 (n = 34), 65\u201379 (n = 61), and \u226580 (n = 57) years old. Stalk-specific antibodies were quantified by ELISA at day 0 and day 28 using recombinant viruses (cH6\/1 and cH14\/3) containing an HA head domain (H6 or H14) from wild bird origin with a stalk domain from human H1 or H3, respectively. The geometric mean titer (GMT) and the fold rise (GMFR) were calculated, and differences were assessed using ANOVA adjusted by the false discovery rate (FDR) and the Wilcoxon tests (p &amp;lt;0.05).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>All age groups elicited some level of increase in anti-stalk antibodies after receiving the influenza vaccine, except for the \u226580-year-old cohort. Additionally, &amp;lt;65-year-old vaccinees had higher group 1 antibody titers versus group 2 before and after vaccination. Similarly, vaccinees within the &amp;lt;50-year-old group showed a higher increase in anti-stalk antibody titers when compared to older individuals (\u226580 years old), especially for group 1 anti-stalk antibodies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Seasonal influenza vaccines can the induction of cross-reactive anti-stalk antibodies against group 1 and group 2 HAs. However, low responses were observed in older groups, highlighting the impact of immunosenescence in adequate humoral immune responses.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2023.1194073","type":"journal-article","created":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T04:15:46Z","timestamp":1685333746000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Group 1 and group 2 hemagglutinin stalk antibody response according to age"],"prefix":"10.3389","volume":"14","author":[{"given":"Laura","family":"S\u00e1nchez-de Prada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iv\u00e1n","family":"Sanz-Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weina","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Palese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ra\u00fal","family":"Ortiz de Lejarazu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Mar\u00eda","family":"Eiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adolfo","family":"Garc\u00eda-Sastre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Aydillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,5,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7189\/jogh.09.020421","article-title":"Global mortality associated with seasonal influenza epidemics: new burden estimates and predictors from the GLaMOR project","volume":"9","author":"Paget","year":"2019","journal-title":"J Glob Health"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2458-14-813","article-title":"Annual public health and economic benefits of seasonal influenza vaccination: a European estimate","volume":"14","author":"Preaud","year":"2014","journal-title":"BMC Public Health"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2017.1334554","article-title":"Repeated annual influenza vaccination and vaccine effectiveness: review of evidence","volume":"16","author":"Belongia","year":"2017","journal-title":"Expert Rev Vaccines"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1089\/vim.2017.0129","article-title":"Antibody immunodominance: the key to understanding influenza virus antigenic drift","volume":"31","author":"Altman","year":"2018","journal-title":"Viral Immunol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-019-0143-6","article-title":"The human antibody response to influenza a virus infection and vaccination","volume":"19","author":"Krammer","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"10432","DOI":"10.1038\/s41598-018-28706-1","article-title":"The influenza virus hemagglutinin head evolves faster than the stalk domain","volume":"8","author":"Kirkpatrick","year":"2018","journal-title":"Sci Rep"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/J.TIM.2014.01.010","article-title":"Bat-derived influenza-like viruses H17N10 and H18N11","volume":"22","author":"Wu","year":"2014","journal-title":"Trends Microbiol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1002\/biot.201400393","article-title":"Emerging influenza viruses and the prospect of a universal influenza virus vaccine","volume":"10","author":"Krammer","year":"2015","journal-title":"Biotechnol J"},{"key":"B9","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/s41541-022-00583-w","article-title":"Transcriptome signatures preceding the induction of anti-stalk antibodies elicited after universal influenza vaccination","volume":"7","author":"Aydillo","year":"2022","journal-title":"NPJ Vaccines"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(82)90135-0","article-title":"The antigenic structure of the influenza virus A\/PR\/8\/34 hemagglutinin (H1 subtype)","volume":"31","author":"Caton","year":"1982","journal-title":"Cell"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/290713a0","article-title":"Antigenic structure of influenza virus haemagglutinin defined by hybridoma antibodies","volume":"290","author":"Gerhard","year":"1981","journal-title":"Nature"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2670","DOI":"10.1080\/22221751.2022.2135460","article-title":"Immunodominance hierarchy after seasonal influenza vaccination","author":"S\u00e1nchez-de Prada","year":"2022","journal-title":"Emerg Microbes Infect"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e51112","DOI":"10.3791\/51112","article-title":"Expression of functional recombinant hemagglutinin and neuraminidase proteins from the novel H7N9 influenza virus using the baculovirus expression system","volume":"81","author":"Margine","year":"2013","journal-title":"J Vis Exp"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PONE.0043603","article-title":"A carboxy-terminal trimerization domain stabilizes conformational epitopes on the stalk domain of soluble recombinant hemagglutinin substrates","volume":"7","author":"Krammer","year":"2012","journal-title":"PloS One"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.03060-15","article-title":"Influenza a viruses expressing intra- or intergroup chimeric hemagglutinins","volume":"90","author":"Chen","year":"2016","journal-title":"J Virol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3684","article-title":"Defining the antibody cross-reactome directed against the influenza virus surface glycoproteins","volume":"18","author":"Nachbagauer","year":"2017","journal-title":"Nat Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/CMR.00084-18","article-title":"Factors that influence the immune response to vaccination","volume":"32","author":"Zimmermann","year":"2019","journal-title":"Clin Microbiol Rev"},{"key":"B18","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jcv.2019.08.009","article-title":"Influenza virus-specific CD4+ and CD8+ T cell-mediated immunity induced by infection and vaccination","volume":"119","author":"Jansen","year":"2019","journal-title":"J Clin Virol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/nyas.12462","article-title":"Continuing challenges in influenza","volume":"1323","author":"Webster","year":"2014","journal-title":"Ann N Y Acad Sci"},{"key":"B20","doi-asserted-by":"publisher","first-page":":100130","DOI":"10.1016\/J.XCRM.2020.100130","article-title":"Pre-existing hemagglutinin stalk antibodies correlate with protection of lower respiratory symptoms in flu-infected transplant patients","volume":"1","author":"Aydillo","year":"2020","journal-title":"Cell Rep Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00735-12","article-title":"B cell response and hemagglutinin stalk-reactive antibody production in different age cohorts following 2009 H1N1 influenza virus vaccination","volume":"20","author":"Sangster","year":"2013","journal-title":"Clin Vaccine Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":":e01996-15","DOI":"10.1128\/mBio.01996-15","article-title":"Age dependence and isotype specificity of influenza virus hemagglutinin stalk-reactive antibodies in humans","volume":"7","author":"Nachbagauer","year":"2016","journal-title":"MBio"},{"key":"B23","doi-asserted-by":"publisher","first-page":":100029","DOI":"10.1016\/j.jvacx.2019.100029","article-title":"No evidence of antigenic seniority in hemagglutinin specific antibody responses after adjuvanted pandemic 2009 influenza vaccination","volume":"2","author":"Madsen","year":"2019","journal-title":"Vaccine X"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20101352","article-title":"Broadly cross-reactive antibodies dominate the human b cell response against 2009 pandemic H1N1 influenza virus infection","volume":"208","author":"Wrammert","year":"2011","journal-title":"J Exp Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":":e00150-11","DOI":"10.1128\/mBio.00150-11","article-title":"Why do influenza virus subtypes die out","volume":"2","author":"Palese","year":"2011","journal-title":"A Hypothesis MBio"},{"key":"B26","doi-asserted-by":"publisher","first-page":":198ra107","DOI":"10.1126\/scitranslmed.3006637","article-title":"Neutralizing antibodies against previously encountered influenza virus strains increase over time: a longitudinal analysis","volume":"5","author":"Miller","year":"2013","journal-title":"Sci Transl Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":":17","DOI":"10.3390\/vaccines5030017","article-title":"Heterologous humoral response against H5N1, H7N3, and H9N2 avian influenza viruses after seasonal vaccination in a european elderly population","volume":"5","author":"Sanz","year":"2017","journal-title":"Vaccines (Basel)"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jix173","article-title":"The doctrine of original antigenic sin: separating good from evil","volume":"215","author":"Monto","year":"2017","journal-title":"J Infect Dis"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1172\/JCI41902","article-title":"Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine","volume":"120","author":"Corti","year":"2010","journal-title":"J Clin Invest"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.03509-12","article-title":"H3N2 influenza virus infection induces broadly reactive hemagglutinin stalk antibodies in humans and mice","volume":"87","author":"Margine","year":"2013","journal-title":"J Virol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1172\/JCI123366","article-title":"Subdominance and poor intrinsic immunogenicity limit humoral immunity targeting influenza HA stem","volume":"129","author":"Tan","year":"2019","journal-title":"J Clin Invest"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2015.05.004","article-title":"Immunosenescence: implications for response to infection and vaccination in older people","volume":"82","author":"Pera","year":"2015","journal-title":"Maturitas"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/0047-6374(80)90115-3","article-title":"Nature of the decline in antigen-induced humoral immunity with age","volume":"14","author":"Makinodan","year":"1980","journal-title":"Mech Ageing Dev"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01960","article-title":"Immunosenescence and inflamm-aging as two sides of the same coin: friends or foes","volume":"8","author":"Fulop","year":"2018","journal-title":"Front Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-1118-7","article-title":"A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial","volume":"27","author":"Nachbagauer","year":"2021","journal-title":"Nat Med"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/vaccines8040704","article-title":"Adjuvanted influenza vaccines elicits higher antibody responses against the A(H3N2) subtype than non-adjuvanted vaccines","volume":"8","author":"S\u00e1nchez de Prada","year":"2020","journal-title":"Vaccines (Basel)"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1194073\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T04:15:50Z","timestamp":1685333750000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1194073\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,29]]},"references-count":36,"alternative-id":["10.3389\/fimmu.2023.1194073"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1194073","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,29]]},"article-number":"1194073"}}